Cargando…

Increased Oxidation as an Additional Mechanism Underlying Reduced Clot Permeability and Impaired Fibrinolysis in Type 2 Diabetes

Aims. We sought to investigate whether enhanced oxidation contributes to unfavorable fibrin clot properties in patients with diabetes. Methods. We assessed plasma fibrin clot permeation (K (s), a measure of the pore size in fibrin networks) and clot lysis time induced by recombinant tissue plasminog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lados-Krupa, Anna, Konieczynska, Malgorzata, Chmiel, Artur, Undas, Anetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556060/ https://www.ncbi.nlm.nih.gov/pubmed/26357663 http://dx.doi.org/10.1155/2015/456189

Ejemplares similares

Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk
por: Gajos, Grzegorz, et al.
Publicado: (2015)

Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long‐term follow‐up study
por: Bryk, Agata Hanna, et al.
Publicado: (2021)

Increased Plasma Clot Permeability and Susceptibility to Lysis Are Associated with Heavy Menstrual Bleeding of Unknown Cause: A Case-Control Study
por: Szczepaniak, Piotr, et al.
Publicado: (2015)

Impaired Fibrinolysis in Patients with Isolated Aortic Stenosis is Associated with Enhanced Oxidative Stress
por: Siudut, Jakub, et al.
Publicado: (2020)

Specific changes in circulating cytokines and growth factors induced by exercise stress testing in asymptomatic aortic valve stenosis
por: Kolasa-Trela, Renata, et al.
Publicado: (2017)

Unexplained thrombosis of the aortic arch with distal embolization in a patient with altered fibrin clot properties
por: Ciurus, Tomasz, et al.
Publicado: (2012)

Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma
por: Bønløkke, Søren Thorgaard, et al.
Publicado: (2023)

Clot Structure and Fibrinolysis in Thrombosis and Hemostasis
por: Bagoly, Zsuzsa, et al.
Publicado: (2017)

Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence
por: Undas, Anetta
Publicado: (2017)

Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study
por: Paszek, Elżbieta, et al.
Publicado: (2023)

Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Impaired fibrinolysis and lower levels of plasma α(2)-macroglobulin are associated with an increased risk of severe asthma exacerbations
por: Bazan-Socha, Stanislawa, et al.
Publicado: (2017)

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception
por: Piróg, Magdalena, et al.
Publicado: (2019)

Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease
por: Bochenek, Maciej, et al.
Publicado: (2012)

Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot properties
por: Skuza, Anna Aleksandra, et al.
Publicado: (2018)

Accelerated fibrin clot degradation is associated with arterial thromboembolism in patients following venous thrombosis: a cohort study
por: Mrozinska, Sandra, et al.
Publicado: (2021)

Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein
por: Szułdrzyński, Konstanty, et al.
Publicado: (2020)

Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review
por: de Vries, Judith J., et al.
Publicado: (2020)

Fibrinolysis and Beyond: Bridging the Gap between Local and Systemic Clot Removal
por: Knauer, K., et al.
Publicado: (2011)

Combination of ultrasound and rtPA enhances fibrinolysis in an In Vitro clot system
por: Masomi-Bornwasser, Julia, et al.
Publicado: (2017)

The Gilded Clot: Review of Metal-Modulated Platelet Activation, Coagulation, and Fibrinolysis
por: Nielsen, Vance G., et al.
Publicado: (2023)

Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study
por: Polak, Maciej Wiktor, et al.
Publicado: (2019)

Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis
por: Sobczak, Amélie I. S., et al.
Publicado: (2020)

Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia
por: Nowakowski, Tomasz, et al.
Publicado: (2019)

Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis
por: Bryk, Agata H., et al.
Publicado: (2019)

Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
por: Undas, Anetta, et al.
Publicado: (2008)

Lp(a) is not associated with diabetes but affects fibrinolysis and clot structure ex vivo
por: Månsson, Marianne, et al.
Publicado: (2014)

Correction: Combination of ultrasound and rtPA enhances fibrinolysis in an In Vitro clot system
por: Masomi-Bornwasser, Julia, et al.
Publicado: (2018)

Congruent identification of imbalanced fibrinolysis by 2 distinct clot lysis time assays
por: Driever, Ellen G., et al.
Publicado: (2023)

Optimization of quantitative proteomic analysis of clots generated from plasma of patients with venous thromboembolism
por: Stachowicz, Aneta, et al.
Publicado: (2017)

Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture
por: Spinthakis, Nikolaos, et al.
Publicado: (2019)

Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism
por: Kupis, Robert W., et al.
Publicado: (2019)

Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19
por: Wygrecka, Malgorzata, et al.
Publicado: (2022)

Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation
por: Gajos, Grzegorz, et al.
Publicado: (2018)

Unfavourably altered plasma clot properties in patients with primary Raynaud’s phenomenon: association with venous thromboembolism
por: Żuk, Joanna, et al.
Publicado: (2019)

Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation
por: Ząbczyk, Michał, et al.
Publicado: (2020)

Shrimp Alpha-2-Macroglobulin Prevents the Bacterial Escape by Inhibiting Fibrinolysis of Blood Clots
por: Chaikeeratisak, Vorrapon, et al.
Publicado: (2012)

Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism
por: Stachowicz, Aneta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2g9l04f5r7i8vlqrq4b3bp9cvb